wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38514440-17CDAF50-929B-4978-8988-AB76AF1E3045
Q38514440-17CDAF50-929B-4978-8988-AB76AF1E3045
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38514440-17CDAF50-929B-4978-8988-AB76AF1E3045
Axitinib: from preclinical development to future clinical perspectives in renal cell carcinoma.
P2860
Q38514440-17CDAF50-929B-4978-8988-AB76AF1E3045
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38514440-17CDAF50-929B-4978-8988-AB76AF1E3045
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6eaee6eb2155a8f8ea9e06d4e8dee435ed46cb9a
P2860
Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial.